Table 1.
Patient characteristics
| Characteristics | |
|---|---|
| Study population | |
| Number of patient | 81 |
| Age, median (range) | 39 (0–66) |
| Male/female | 46/35 |
| Diagnosis | |
| Leukemia/MDS | 51 |
| Lymphoma/myeloma | 22 |
| Solid tumors | 3 |
| Non‐malignant conditions | 5 |
| Stem cell source | |
| BMT | 38 |
| PBSCT | 13 |
| CBT | 30 |
| Conditioning regimen | |
| Reduced intensity | 40 |
| Myeloablative | 41 |
| GVHD prophylaxis | |
| Tacrolimus based | 66 |
| Cyclosporine based | 15 |
| Diagnosis | |
| GI‐GVHD (GI stage 1, 2, 3, 4) | 32 (14, 5, 3, 10) |
| Non GI‐GVHD | 49 |
| Non GI‐GVHD enteritis | 26 |
| No intestinal symptoms | 23 |
BMT, bone marrow transplantation; PBSCT, peripheral blood stem cell transplantation; CBT, cord blood transplantation; GI‐GVHD, gastrointestinal graft‐versus‐host disease.